NCT07091695 2025-11-12Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+IpilimumabBristol-Myers SquibbCompleted100 enrolled
NCT05704933 2025-10-20Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesH. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Completed1 enrolled